A Novel Chinese Herbal and Corresponding Chemical Formula for Cancer Treatment by Targeting Tumor Maintenance, Progression, and Metastasis.
- Song YC, Lee DY and Yeh PY (2022).
- Front Pharmacol.
- PubMed:
- 35721174
Researchers investigated an herbal combination of four African medicinal plants known as PHELA as a potential therapy for COVID-19. In vitro testing found that PHELA inhibited > 90% of SARS-CoV-2 and SARS-CoV infection as well as close to 100% of MERS-CoV infection. In silico docking studies showed strong binding energy interactions between compounds in PHELA and SARS-CoV-2 proteins. PHELA has potential as a COVID-19 therapeutic.
Researchers have isolated nine sesquiterpenoids from Stellera chamaejasme roots, five of which are previously undescribed. These were tested for their ability to inhibit NO production in BV2 cells induced by LPS. Stellerasespene A was found to have higher inhibitory activity than minocycline, a positive control, indicating its potential use as an anti-inflammatory agent.